Product Name: Anti-Human EGFR/ERBB1/HER1 Antibody (SAA2536)
The Anti-Human EGFR/ERBB1/HER1 Antibody (SAA2536) is a highly specific and potent antibody designed for the detection and inhibition of the epidermal growth factor receptor (EGFR), also known as ERBB1 or HER1. This antibody is produced through a rigorous process of monoclonal antibody development and purification, ensuring high quality and reproducibility.
Biological Function:
EGFR is a transmembrane receptor that plays a crucial role in cell growth, proliferation, and survival. It is overexpressed in various types of cancer, making it an attractive target for cancer therapy. The Anti-Human EGFR/ERBB1/HER1 Antibody (SAA2536) binds to the extracellular domain of EGFR, inhibiting its activation and downstream signaling pathways. This leads to the inhibition of tumor growth and progression.
Main Applications:
The Anti-Human EGFR/ERBB1/HER1 Antibody (SAA2536) has a wide range of applications in both research and clinical settings. Its main use is in cancer research, particularly in the study of EGFR-driven cancers such as lung, breast, and colorectal cancer. It can also be used in diagnostic assays for the detection of EGFR expression in patient samples.
Experimental Use Cases:
In addition to its main applications, the Anti-Human EGFR/ERBB1/HER1 Antibody (SAA2536) has been used in various experimental settings. It has been shown to effectively inhibit EGFR signaling in cell culture and animal models of cancer. Furthermore, it has been used in combination with other targeted therapies to enhance their anti-tumor effects. Its use in pre-clinical studies has paved the way for its potential use in future clinical trials.
This antibody is highly specific for EGFR and has been extensively tested for its potency and specificity. Its use in cancer research and diagnostic assays has been well-documented, making it a valuable tool for scientists and clinicians alike. With its ability to inhibit EGFR signaling, the Anti-Human EGFR/ERBB1/HER1 Antibody (SAA2536) shows great potential for the development of targeted cancer therapies.
Structure:
To summarize, the Anti-Human EGFR/ERBB1/HER1 Antibody (SAA2536) is a highly specific and potent antibody with a crucial role in cancer research and diagnosis. Its biological function, main applications, and experimental use cases make it a valuable tool for scientists and clinicians working towards the development of targeted cancer therapies. With its ability to inhibit EGFR signaling, this antibody holds great promise for the future of cancer treatment.
There are no reviews yet.